News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current CUV market cap is 599.74M. The company's latest EPS is AUD 0.7112 and P/E is 16.83.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 32.69M | 48.11M | 65.94M | 78.34M | 88.74M |
| Operating Income | 10.33M | 26.83M | 33.27M | 40.94M | 44.12M |
| Net Income | 15.05M | 24.73M | 20.88M | 30.61M | 35.64M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 81.54M | 108.57M | 143.95M | 193.71M | 231.12M |
| Total Liabilities | 9.48M | 9.83M | 18.39M | 29.08M | 28.11M |
| Total Equity | 72.07M | 98.74M | 125.56M | 164.63M | 203.01M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | 14.19M | 19.26M | 39.87M | 36.91M | 37.05M |
| Investing | -888k | -854k | -434k | -31.85M | -29.03M |
| Financing | -1.49M | -1.48M | -1.5M | -2.24M | -3.57M |
| Market Cap | 599.74M |
| Price to Earnings Ratio | 16.83 |
| Price to Sales Ratio | 6.76 |
| Price to Cash Ratio | 3.26 |
| Price to Book Ratio | 2.95 |
| Dividend Yield | - |
| Shares Outstanding | 50.1M |
| Average Volume (1 week) | 81.27k |
| Average Volume (1 Month) | 132.56k |
| 52 Week Change | -25.23% |
| 52 Week High | 17.71 |
| 52 Week Low | 11.715 |
| Spread (Intraday) | 0.02 (0.17%) |
| Company Name | Clinuvel Pharmaceuticals Limited |
| Address |
level 11 melbourne, victoria 3000 |
| Website | https://www.clinuvel.com |
| Industry | drugs-health r&d/testing labs (H8) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
